A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients

Metabolism: Clinical and Experimental

Volumn 51, Issue 8, 2002, Pages 1071-1076

  Bruckert, E ^a   Giral, P ^a   Ratziu, V ^a   Poynard, T ^a   Chapman, M J ^a   Opolon, P ^a   Turpin, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FIBRIC ACID DERIVATIVE; GAMMA GLUTAMYLCYCLOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; STATIN DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COHORT ANALYSIS; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; LIVER INJURY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MULTIVARIATE ANALYSIS; NORMAL VALUE; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PLASMA; PRIORITY JOURNAL; PROGNOSIS; SERUM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0036347232     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.34046     Document Type: Article

References (42)

1. Elevated alanine aminotransferase in blood donors: Role of different factors and multiple viral infections
2. Increased serum gamma-glutamyl transferase in hypertriglyceridemia: Comparison with serum pseudocholineesterase
3. Transaminases of serum and tissues in hypercholesterolemia
4. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
5. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
6. The natural history of nonalcoholic fatty liver: A follow-up study
7. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
8. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
9. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
10. The Tromso Study. Distribution and population determinants of gamma glutamyl transferase
11. Serum gamma glutamyl transpeptidase level and blood pressure in non-drinkers: A possible pathogenic role of fatty liver in obesity-related hypertension
12. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
13. Liver pathology and the metabolic syndrome X in severe obesity
14. Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients
15. Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferase
16. Mild liver abnormalities are associated with elevated plasma factor VII and protein C in hypertriglyceridemic patients
17. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men - Role of the metabolic syndrome
18. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo
19. Subcutaneous adipose tissue expression of plasminogen activator-1 gene during very low calorie diet in obese subjects
20. Morbid obesity: Definitions, epidemiology, and methodological problems
21. Primary care: Guidelines for healthy weight
22. Definition, diagnosis, and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus
23. Méthode sélectionnée pour le dosage du cholestérol des lipoprotéines non précipitables par le phospho-tungstate de sodium en présence de chlorure de magnesium
24. Recommendations for carrying out standard ECCLS procedures (1988) for the catalytic concentrations of creatine kinase, aspartate aminotransferase, alanine aminotransferase and gamma-glutamyltransferase at 37°
25. Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC group
26. The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease
27. Liver in obesity
28. Liver and biliary ultrasonography in diabetic and non-diabetic obese women
29. Liver morphology in morbid obesity: A literature study
30. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
31. L'hépatite C
32. Risk factors of extensive liver fibrosis in overweight patients with elevated liver enzymes
33. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies
34. Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome
35. Ischemia/reperfusion alters uric acid and ascorbic acid levels in liver
36. Role of xanthine oxidase in delayed lipid peroxidation in rat liver induced by acute exhausting exercise
37. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis?
38. Cytosolic triglycerides and oxidative stress in central obesity: The missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?
39. Intravenous load of fructose and fructose 1,6-diphosphate: Effects on uricemia in patients with nonalcoholic liver disease
40. Diagnostic significance of determining the blood content of lactic and uric acids in chronic liver lesions of alcoholic and viral etiologies
41. Non-alcoholic steatohepatitis: Another disease of affluence
42. Fatty liver-an additional and treatable feature of the insulin resistance syndrome